ARVO 2021: Faricimab Could Cut Down on Injections for Age-Related Macular Degeneration
Outcomes were non-inferior to aflibercept despite longer periods between injections
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.